The population density of Kutztown, PA was 3,081 in 2018.

Population Density

Population Density is computed by dividing the total population by Land Area Per Square Mile.

Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API - Notes:

1. ODN datasets and APIs are subject to change and may differ in format from the original source data in order to provide a user-friendly experience on this site.

2. To build your own apps using this data, see the ODN Dataset and API links.

3. If you use this derived data in an app, we ask that you provide a link somewhere in your applications to the Open Data Network with a citation that states: "Data for this application was provided by the Open Data Network" where "Open Data Network" links to http://opendatanetwork.com. Where an application has a region specific module, we ask that you add an additional line that states: "Data about REGIONX was provided by the Open Data Network." where REGIONX is an HREF with a name for a geographical region like "Seattle, WA" and the link points to this page URL, e.g. http://opendatanetwork.com/region/1600000US5363000/Seattle_WA

Geographic and Population Datasets Involving Kutztown, PA

  • API

    COVID-19 Aggregate Death Data Current Daily County Health

    data.pa.gov | Last Updated 2021-09-28T13:34:30.000Z

    This dataset contains aggregate death data at the state and county level for Pennsylvania residents. The data are displayed by county, date, death counts, averages, rates based on population. Pennsylvania statewide numbers are listed with Pennsylvania named as the county for the statewide totals. Do not add up the entire file (all rows) or counts will be duplicated. Data will be updated between 9-11 am every day.

  • API

    COVID-19 Aggregate Cases Current Daily County Health

    data.pa.gov | Last Updated 2021-09-28T13:34:46.000Z

    This dataset contains aggregate COVID-19 case counts and rates by date of first report for all counties in Pennsylvania and for the state as a whole. Counts include both confirmed and probable cases as defined by the Council of State and Territorial Epidemiologists (CSTE). At present, a person is counted as a case only once. Note that case counts by date of report are influenced by a variety of factors, including but not limited to testing availability, test ordering patterns (such as day of week patterns), labs reporting backlogged test results, and mass screenings in nursing homes, workplaces, schools, etc. Case reports received without a patient address are assigned to the county of the ordering provider or facility based on provider zip code. Cases reported with a residential address that does not match to a known postal address per the commonwealth geocoding service are assigned to a county based on the zip code of residence. Many zip codes cross county boundaries so there is some degree of misclassification of county. All counts may change on a daily basis due to reassignment of jurisdiction, removal of duplicate case reports, correction of errors, and other daily data cleaning activities. Downloaded data represents the best information available as of the previous day. <br> Data will be updated between 9-11 am every day.

  • API

    COVID-19 Vaccinations by Residence Current County Health

    data.pa.gov | Last Updated 2021-09-28T18:45:58.000Z

    This dataset contains aggregate data of COVID vaccines administered to citizens based on county of residence. Data includes counts of individuals who received a vaccine dose that provides partial coverage against the disease and counts of individuals that received a vaccine dose that provides full coverage against the disease. Suppression applies for quantities less than 5. Data only includes information reported to PA-SIIS, the Pennsylvania Statewide Immunization Information System.

  • API

    Emergency Department (ED) Visits for Overdose Identified Through Syndromic Surveillance Quarter 3 2016 - Current Quarterly County Health

    data.pa.gov | Last Updated 2020-05-28T18:04:43.000Z

    View quarterly trends in overdose rates for Any Drug Overdoses, Any Opioid Overdoses and Heroin Overdoses at the state and county level. Please see Overdose Data Technical Notes for additional details: : https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

  • API

    Educational Attainment by Age Range and Gender 2009-2016 County Annual Education

    data.pa.gov | Last Updated 2018-11-05T16:26:18.000Z

    County level educational attainment data on the adult working aged population (25-64) by age range and gender. Data is sourced from the US Census Bureau’s American Community Survey (ACS) 5-year estimates allowing for increased statistical reliability of the data for less populated areas and small population subgroups. More information here - https://www.census.gov/data/developers/data-sets/acs-5year.html

  • API

    Bronx Zip Population and Density

    bronx.lehman.cuny.edu | Last Updated 2012-10-21T14:06:17.000Z

    2010 Census Data on population, pop density, age and ethnicity per zip code

  • API

    Dispensation Data without Buprenorphine Quarter 3 2016 - Current Quarterly County Health

    data.pa.gov | Last Updated 2021-09-28T14:08:20.000Z

    View quarterly trends in opioid dispensation data for all Schedule II-V opioids. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx More information from U.S. Department of Justice https://www.deadiversion.usdoj.gov/schedules/ Schedule I Controlled Substances Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ("Ecstasy"). Schedule II/IIN Controlled Substances (2/2N) Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence. Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone. Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®). Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital. Schedule III/IIIN Controlled Substances (3/3N) Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®). Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone. Schedule IV Controlled Substances Substances in this schedule have a low potential for abuse relative to substances in Schedule III. Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®). Schedule V Controlled Substances Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.

  • API

    Counts and Rates of New HIV Diagnoses Among Individuals Using Injection Drugs January 2016 - Current Monthly County & Statewide Health

    data.pa.gov | Last Updated 2021-04-20T18:42:52.000Z

    This indicator includes the count and rate of new HIV diagnoses among individuals using injection drugs per 100,000 individuals estimated to have Drug Use Disorder.

  • API

    Risky Prescribing Measures Quarter 3 2016 - Current Quarterly County & Statewide Health

    data.pa.gov | Last Updated 2021-09-10T19:18:48.000Z

    View quarterly trends in Risky Prescribing Measures, including: o Number/Rate of Individuals Seeing 5+ Prescribers and 5+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 4+ Prescribers and 4+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 3+ Prescribers and 3+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals with an Average Daily MME >50, >90 or >120: Average Daily MME is calculated as the sum of the total MME on each day in a time period based on all prescriptions an individual has filled divided by the number of days in the prescription(s). Measures include the number and rate of individuals prescribed greater than 50 MME per day, greater than 90 MME per day, or greater than 120 MME per day and is based on the patient’s county of residence. o Number/Rate of Individuals with Overlapping Opioid/Benzodiazepine Prescriptions: Number of individuals receiving overlapping opioid and benzodiazepine prescriptions during a given quarter. This measure is based on the patients’ county of residence. o Number/Rate of Individuals with > 30 Days of Overlapping Opioid/Benzodiazepine Prescriptions: Number and rate of individuals receiving overlapping opioid and benzodiazepine prescriptions for 30 days or more during a given quarter using state/county populations as denominators. This measure is based on the patients’ county of residence. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

  • API

    Buprenorphine Dispensation Data Quarter 3 2016 - Current Quarterly Statewide Health

    data.pa.gov | Last Updated 2021-09-28T15:01:18.000Z

    View quarterly trends in buprenorphine dispensation data. Please note that buprenorphine data received by the PDMP is restricted to prescriptions filled by pharmacies. The PDMP does not collect information on the reason a controlled substance is prescribed, nor does it collect data from substance abuse treatment facilities or dispensing prescribers providing buprenorphine for substance abuse treatment. Buprenorphine is sometimes prescribed off-label for pain. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx